Biosimilars for adalimumab (Humira) had similar efficacy and safety profiles for psoriasis when compared to the original. The meta-analysis appeared recently in the Journal of Dermatological Treatment ...

Biosimilars demonstrate comparable drug survival and safety with adalimumab among new users, but patients switching from Humira (the originator product) to biosimilars had a 35% higher discontinuation ...

Clobex spray is a powerful corticosteroid that can clear psoriasis symptoms in about four weeks. Cyclosporine is a fast-acting immunosuppressant but can have serious side effects like kidney toxicity.

Credit: Celltrion. Yuflyma, a tumor necrosis factor blocker, was approved in May 2023 as a biosimilar to Humira. Similar PK, efficacy, safety, and immunogenicity data were observed between the ...

Credit: Teva. Simlandi is an interchangeable biosimilar and can be substituted for the reference product without requiring a prescription change. The Food and Drug Administration (FDA) has approved ...